NCT07095491

Brief Summary

The purpose of this study is to evaluate the impact of a self-care and self-efficacy-based hybrid education program implemented for individuals receiving hemodialysis treatment on their clinical findings, psychosocial status (dialysis distress), and comfort levels during the dialysis process. For this purpose, the most important questions to be answered in the study are as follows:

  • What are the clinical findings, psychosocial status (dialysis distress), and comfort levels of hemodialysis patients at the beginning of the study?
  • Does the self-care and self-efficacy-based hybrid education have an impact on the clinical findings, psychosocial status (dialysis distress), and comfort levels of hemodialysis patients? Participants: The intervention group will receive a structured hybrid education program based on self-care and self-efficacy. The control group will not receive any intervention during this period and will continue with routine nursing care (standard treatment).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

Same day

First QC Date

July 24, 2025

Last Update Submit

July 24, 2025

Conditions

Keywords

HemodialysisHybrid EducationRandomized Controlled TrialNursing

Outcome Measures

Primary Outcomes (3)

  • Self-Care Self-Efficacy Scale

    Each item is rated on a 5-point Likert-type scale, ranging from 1 (not at all confident) to 5 (completely confident). The total score, consisting of four subscales and 10 items, ranges from 10 to 50. Higher scores indicate higher self-care and self-efficacy levels during treatment.

    Change from before implementation and 4th week of practice

  • Haemodialysis Distress Thermometer Scale

    The scale includes a thermometer image, rated from 0 to 10. The participant indicates the overall level of distress they have felt over the past week on this scale. 0 = No distress at all, 10 = Unbearable distress. In the Turkish validation study, scores of 5 and above are generally considered clinical distress.

    Change from before implementation and 4th week of practice

  • Hemodialysis Comfort Scale

    The scale, consisting of two subscales, is rated on a 5-point Likert-type scale (1 = never, 5 = always). The total score from the scale ranges from 9 to 45. Higher scores indicate a higher level of comfort for the individual.

    Change from before implementation and 4th week of practice

Study Arms (2)

Experimental group: Intervention: Education group

EXPERIMENTAL

A structured hybrid training program based on self-care and self-efficacy will be implemented for the intervention group.

Other: Experimental

Other: Control group

OTHER

The control group will not receive any different intervention and will continue the process with routine nursing care (standard treatment).

Other: Control

Interventions

A structured hybrid training program based on self-care and self-efficacy will be implemented for the intervention group. The training will be conducted in two sessions, one day per week, over a total of two weeks.

Experimental group: Intervention: Education group
ControlOTHER

The control group will not receive any different intervention and will continue the process with routine nursing care (standard treatment).

Other: Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 18 and over
  • Patients who have been receiving hemodialysis treatment for at least 6 months
  • Those with stable clinical findings
  • Those who have not previously received professional training in self-care and self-sufficiency
  • Those who have the cognitive ability to complete the data collection form
  • Those who do not have a severe visual or auditory impairment
  • Those who can use a smartphone and have access to the WhatsApp application
  • Those who volunteer to participate in the study and sign the Informed Consent Form will be included.

You may not qualify if:

  • Under 18 years of age
  • Patients receiving hemodialysis treatment for less than 6 months
  • Those whose clinical findings fluctuate to the point of being life-threatening
  • Those who have previously received professional training on self-care and self-sufficiency
  • Individuals who declare that they will not be able to attend at least one of the training sessions during the program
  • Individuals who are simultaneously participating in another training program or psychosocial intervention
  • Those who do not have the cognitive capacity to complete the data collection form
  • Individuals who cannot effectively participate in the applications due to visual or hearing impairments
  • Individuals who cannot use a smartphone or do not have access to the WhatsApp application
  • Those who do not wish to participate in the study and who do not sign the Informed Consent Form will not be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Esra Çavuşoğlu, Doctorate

    Mersin University

    STUDY DIRECTOR
  • Esra Köse, Doctorate

    Mersin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Esra Çavuşoğlu, Doctorate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Since hemodialysis patients participating in the study will be in either the training (experimental) or control groups, blinding will not be possible. Researchers will be blinded only during group assignment (groups A and B). Data will be transferred to a computer by the researchers, and a biostatistician independent of the study will analyze the data and report the findings, without knowing which groups A and B are assigned. This will ensure the biostatistician is blinded.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective, parallel, two-arm, randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctorate, Research Assistant

Study Record Dates

First Submitted

July 24, 2025

First Posted

July 31, 2025

Study Start

August 1, 2025

Primary Completion

August 1, 2025

Study Completion

November 1, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share